HomeInsightsStock Comparison

Caplin Point Laboratories Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Caplin Point Laboratories Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Last Updated on: May 04, 2025

Key Highlights

  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1884 as of 02 May 15:30.
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 9.9 on March 2020 to 21.9 on March 2024 . This represents a CAGR of 17.21% over 5 yearsThe P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 18.4 on March 2024 . This represents a CAGR of -6.39% over 5 years.
  • The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 2135 crore on March 2020 to ₹ 10003 crore on March 2024 . This represents a CAGR of 36.18% over 5 yearsThe Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 51797 crore on March 2020 to ₹ 102679 crore on March 2024 . This represents a CAGR of 14.67% over 5 years.
  • The revenue of Caplin Point Laboratories Ltd for the Dec '24 is ₹ 524.32 crore as compare to the Sep '24 revenue of ₹ 503.87 crore. This represent the growth of 4.06% The revenue of Dr Reddys Laboratories Ltd for the Dec '24 is ₹ 8535 crore as compare to the Sep '24 revenue of ₹ 8351 crore. This represent the growth of 2.2%.
  • The ebitda of Caplin Point Laboratories Ltd for the Dec '24 is ₹ 193.64 crore as compare to the Sep '24 ebitda of ₹ 185.43 crore. This represent the growth of 4.43% The ebitda of Dr Reddys Laboratories Ltd for the Dec '24 is ₹ 2427 crore as compare to the Sep '24 ebitda of ₹ 2390 crore. This represent the growth of 1.56%.
  • The net profit of Caplin Point Laboratories Ltd changed from ₹ 104.23 crore to ₹ 140.07 crore over 7 quarters. This represents a CAGR of 18.40% The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1405 crore to ₹ 1404 crore over 7 quarters. This represents a CAGR of -0.03% .
  • The Dividend Payout of Caplin Point Laboratories Ltd changed from 9.57 % on March 2020 to 13.39 % on March 2024 . This represents a CAGR of 6.95% over 5 yearsThe Dividend Payout of Dr Reddys Laboratories Ltd changed from 14.14 % on March 2020 to 15.37 % on March 2024 . This represents a CAGR of 1.68% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

Caplin Point Laboratories Ltd News Hub

News

Caplin Steriles receives USFDA approval for Phytonadione Injectable Emulsion

Caplin Point Laboratories announced that its subsidiary, Caplin Steriles, has been granted...

Read more

23 Apr 2025 12:59

News

Caplin Point Lab arm receives final approval for Phytonadione Injectable Emulsion

The approved product is a generic therapeutic equivalent of the Reference Listed Drug (RLD...

Read more

23 Apr 2025 11:29

News

Caplin Steriles receives USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution

Caplin Steriles (Caplin), a subsidiary company of Caplin Point Laboratories has been grant...

Read more

26 Feb 2025 19:15

News

Caplin Point Lab's subsidiary gets USFDA approval for new eye drop solution

The said drug is a generic therapeutic equivalent version of the Reference Listed Drug (RL...

Read more

26 Feb 2025 14:17

News

Caplin Steriles receives USFDA approval for Procainamide Hydrochloride Injection

Caplin Steriles, a Subsidiary Company of Caplin Point Laboratories, has been granted final...

Read more

05 Feb 2025 20:06

News

Caplin Point Laboratories to hold board meeting

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

01 Feb 2025 10:02

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys announces cessation of subsidiary in Louisiana

Dr. Reddy's Laboratories Inc., USA, a wholly owned subsidiary of the Company, has successf...

Read more

24 Mar 2025 13:48

News

Dr Reddys Laboratories to conduct board meeting

Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 9 M...

Read more

22 Mar 2025 11:01

News

Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US

Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75%...

Read more

13 Mar 2025 18:46

News

Dr Reddys Laboratories allots 11,250 equity shares under ESOS

Dr Reddys Laboratories has allotted 11,250 equity shares under ESOS on 06 March 2025. Powe...

Read more

06 Mar 2025 19:16

News

Dr Reddy's Lab gets EIR from USFDA for Hyderabad facility

The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and confirmed ...

Read more

27 Feb 2025 09:57

News

Dr Reddys Laboratories allots 20,155 equity shares under ESOS

Dr Reddys Laboratories has allotted 20,155 equity shares of Re.1/- each of the Company, fu...

Read more

14 Feb 2025 18:24

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Caplin Point Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd

Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Dr Reddys Laboratories Ltd?

Market cap of Caplin Point Laboratories Ltd is 14,323 Cr while Market cap of Dr Reddys Laboratories Ltd is 98,707 Cr

What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd?

The stock performance of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd?

As of May 4, 2025, the Caplin Point Laboratories Ltd stock price is INR ₹1884.35. On the other hand, Dr Reddys Laboratories Ltd stock price is INR ₹1182.9.

How do dividend payouts of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd compare?

To compare the dividend payouts of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions